Skip to main content
OpenTrials

Clinical trial condition

Mantle-Cell Lymphoma

Explore clinical trials studying Mantle-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

18 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Mantle-Cell Lymphoma trial results

Recruiting

A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain

NCT07029737

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site A Coruña, Spain
  • Research Site Alcorcón, Spain
  • Research Site Badalona, Spain
  • Research Site Barcelona, Spain
View all 22 locations
View Trial Details
Completed

A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma

NCT03323151

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Carle Cancer Center Urbana, Illinois, United States
  • University of Kansas Overland Park, Kansas, United States
View all 14 locations
View Trial Details
Completed

Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)

NCT02631044

Conditions
Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Local Institution - 0006 Birmingham, Alabama, United States
  • Local Institution - 0007 Duarte, California, United States
  • Local Institution - 0010 San Francisco, California, United States
  • Local Institution - 0020 Aurora, Colorado, United States
View all 14 locations
View Trial Details
Completed

Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors

NCT03010982

Conditions
Advanced Solid Tumors, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +17 more
Locations
  • The Clatterbridge Cancer Centre NHS Foundation Trust Bebington, Wirral, United Kingdom
  • Royal Liverpool and Broadgreen University Hospital Trust Liverpool, United Kingdom
View Trial Details

Related conditions